PMV Pharmaceuticals, Inc. SEC filings PMVP
PMV Pharmaceuticals, Inc. has 390 filings in SEC EDGAR's recent list, going back to Mar 2, 2017. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 5, 2026 | Oct 1, 2026 |
| 3 | Initial insider ownership | Oct 5, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 5, 2026 | Oct 1, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 15, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Sep 2, 2026 | Aug 31, 2026 |
| 424B5 | Prospectus supplement | Sep 2, 2026 | — |
| 424B3 | Prospectus | Aug 31, 2026 | — |
| 424B5 | Prospectus supplement | Aug 31, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 31, 2026 | Aug 31, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 28, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 10, 2026 | — |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2026 | Jun 4, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 4, 2026 | — |
| ARS | Annual report to shareholders | Apr 22, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEF 14A | Proxy statement | Apr 22, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| S-8 | Employee stock plan registration | Mar 6, 2026 | — |
| 8-K |
Current report
Results of operations
|
Mar 6, 2026 | Mar 6, 2026 |
| 10-K | Annual report | Mar 6, 2026 | Dec 31, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 4, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 9, 2026 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 12, 2025 | — |
| 4 | Insider transaction | Oct 29, 2025 | Oct 27, 2025 |
| 4 | Insider transaction | Oct 27, 2025 | Oct 23, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 27, 2025 | — |
| 144 | Notice of proposed sale | Oct 23, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 23, 2025 | — |
| 4 | Insider transaction | Sep 12, 2025 | Sep 10, 2025 |
| 144 | Notice of proposed sale | Sep 10, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 10, 2025 | Sep 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jul 3, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2025 | Jun 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 9, 2025 | May 9, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 5, 2025 |
| 3 | Initial insider ownership | Apr 23, 2025 | Apr 21, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 8, 2025 | — |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2025 | Mar 3, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 21, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 10, 2025 | — |
| S-8 | Employee stock plan registration | Jan 28, 2025 | — |
| 4 | Insider transaction | Jan 22, 2025 | Dec 3, 2024 |
| SC 13G | Ownership over 5% (passive) | Dec 12, 2024 | — |
| EFFECT | Filing | Nov 27, 2024 | — |
| 424B3 | Prospectus | Nov 27, 2024 | — |
| CORRESP | Letter to the SEC | Nov 25, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2024 | — |
| S-3 | Shelf registration | Nov 20, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 4 | Insider transaction | Oct 3, 2024 | Aug 13, 2024 |
| 4 | Insider transaction | Oct 3, 2024 | Aug 13, 2024 |
| 4 | Insider transaction | Oct 3, 2024 | Aug 13, 2024 |
| 4 | Insider transaction | Sep 12, 2024 | Sep 11, 2024 |
| 4 | Insider transaction | Sep 12, 2024 | Sep 11, 2024 |
| SC TO-I/A | Filing | Aug 14, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Agreement ended, Results of operations
|
Aug 8, 2024 | Aug 5, 2024 |
| SC TO-I | Filing | Jul 16, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 8, 2024 | — |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2024 | Jun 6, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 24, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 24, 2024 | — |
| DEF 14A | Proxy statement | Apr 24, 2024 | Jun 6, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 9, 2024 | — |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 29, 2024 | — |
| S-8 | Employee stock plan registration | Jan 24, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 23, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 23, 2024 | — |
| 4 | Insider transaction | Jan 22, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Jan 22, 2024 | Jan 18, 2024 |
| 4 | Insider transaction | Jan 22, 2024 | Jan 18, 2024 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Jan 18, 2024 | Jan 18, 2024 |
| 3 | Initial insider ownership | Jan 11, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 5, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Nov 24, 2023 | Nov 22, 2023 |
| 144 | Notice of proposed sale | Nov 22, 2023 | — |
| 4 | Insider transaction | Nov 13, 2023 | Oct 18, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Other events
|
Oct 12, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 11, 2023 | Oct 11, 2023 |
| 4 | Insider transaction | Sep 18, 2023 | Sep 15, 2023 |
| 4 | Insider transaction | Sep 18, 2023 | Sep 15, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 23, 2023 | — |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 4 | Insider transaction | Aug 8, 2023 | Aug 7, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 7, 2023 | — |
| 4 | Insider transaction | Jun 12, 2023 | Jun 8, 2023 |
| 4 | Insider transaction | Jun 12, 2023 | Jun 8, 2023 |
| 4 | Insider transaction | Jun 12, 2023 | Jun 8, 2023 |
| 4 | Insider transaction | Jun 12, 2023 | Jun 8, 2023 |
| 4 | Insider transaction | Jun 12, 2023 | Jun 8, 2023 |
| 4 | Insider transaction | Jun 12, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2023 | Jun 8, 2023 |
| SC 13G | Ownership over 5% (passive) | May 19, 2023 | — |
| 4 | Insider transaction | May 15, 2023 | May 12, 2023 |
| 4 | Insider transaction | May 15, 2023 | May 12, 2023 |
| 4 | Insider transaction | May 15, 2023 | May 12, 2023 |
| 4 | Insider transaction | May 15, 2023 | May 12, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | May 10, 2023 | — |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| EFFECT | Filing | Apr 28, 2023 | — |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 28, 2023 | Apr 24, 2023 |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 8, 2023 |
| POS AM | Filing | Mar 1, 2023 | — |
| 10-K | Annual report | Mar 1, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2023 | Mar 1, 2023 |
| POSASR | Filing | Mar 1, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 31, 2023 | — |
| 4 | Insider transaction | Jan 30, 2023 | Nov 25, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 25, 2023 | — |
| S-8 | Employee stock plan registration | Jan 25, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 24, 2023 | — |
| 4 | Insider transaction | Nov 8, 2022 | Nov 4, 2022 |
| 3 | Initial insider ownership | Nov 8, 2022 | Nov 3, 2022 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 4, 2022 | Nov 3, 2022 |
| 4 | Insider transaction | Sep 13, 2022 | Sep 9, 2022 |
| 4 | Insider transaction | Sep 13, 2022 | Sep 9, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| SC 13G | Ownership over 5% (passive) | Jul 11, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 7, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Jun 17, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 8, 2022 | Jun 7, 2022 |
| 4 | Insider transaction | Jun 6, 2022 | Jun 2, 2022 |
| 4 | Insider transaction | Jun 6, 2022 | Jun 2, 2022 |
| 4 | Insider transaction | Jun 6, 2022 | Jun 2, 2022 |
| 4 | Insider transaction | Jun 6, 2022 | Jun 2, 2022 |
| 4 | Insider transaction | Jun 6, 2022 | Jun 2, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2022 | Jun 2, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PMVP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Princeton, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1699382
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.